| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 18 | 2023 | 1067 | 4.500 |
Why?
|
| DNA-Binding Proteins | 22 | 2023 | 2164 | 3.760 |
Why?
|
| E2F1 Transcription Factor | 13 | 2020 | 51 | 3.110 |
Why?
|
| Nuclear Proteins | 17 | 2023 | 1339 | 2.740 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2023 | 791 | 2.220 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2021 | 389 | 2.120 |
Why?
|
| 14-3-3 Proteins | 5 | 2022 | 56 | 2.080 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 704 | 1.620 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 2767 | 1.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2022 | 508 | 1.420 |
Why?
|
| DNA Damage | 12 | 2021 | 545 | 1.390 |
Why?
|
| Apoptosis | 11 | 2014 | 1928 | 1.320 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 465 | 1.150 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2023 | 36 | 1.060 |
Why?
|
| Ubiquitination | 5 | 2021 | 183 | 1.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 6 | 2021 | 104 | 0.980 |
Why?
|
| DNA Repair | 4 | 2021 | 631 | 0.940 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2019 | 509 | 0.940 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 207 | 0.920 |
Why?
|
| DNA Replication | 5 | 2021 | 363 | 0.890 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 259 | 0.850 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 3754 | 0.840 |
Why?
|
| Phosphorylation | 15 | 2021 | 1707 | 0.820 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2020 | 52 | 0.810 |
Why?
|
| Checkpoint Kinase 1 | 3 | 2021 | 30 | 0.800 |
Why?
|
| GATA3 Transcription Factor | 1 | 2022 | 39 | 0.790 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 2655 | 0.780 |
Why?
|
| Promoter Regions, Genetic | 7 | 2019 | 1418 | 0.770 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 589 | 0.750 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 36 | 0.720 |
Why?
|
| Protein Binding | 11 | 2020 | 1844 | 0.700 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 129 | 0.670 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 382 | 0.660 |
Why?
|
| Transcription Factors | 10 | 2021 | 2712 | 0.660 |
Why?
|
| Down-Regulation | 4 | 2012 | 716 | 0.650 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 267 | 0.630 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2021 | 557 | 0.630 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 475 | 0.610 |
Why?
|
| Actins | 1 | 2021 | 350 | 0.600 |
Why?
|
| Carcinogenesis | 1 | 2021 | 363 | 0.590 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 62 | 0.580 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 123 | 0.570 |
Why?
|
| HEK293 Cells | 7 | 2015 | 814 | 0.570 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 616 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2022 | 2121 | 0.540 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1756 | 0.510 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 821 | 0.490 |
Why?
|
| Cell Cycle | 6 | 2020 | 626 | 0.490 |
Why?
|
| Ubiquitin | 3 | 2012 | 150 | 0.490 |
Why?
|
| S Phase | 5 | 2020 | 78 | 0.490 |
Why?
|
| Cell Line | 11 | 2020 | 2841 | 0.480 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 497 | 0.480 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 65 | 0.480 |
Why?
|
| Mutation, Missense | 2 | 2017 | 931 | 0.470 |
Why?
|
| Oxidative Stress | 1 | 2020 | 869 | 0.460 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2014 | 10 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 624 | 0.450 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 872 | 0.450 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2014 | 22 | 0.450 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 70 | 0.440 |
Why?
|
| Humans | 40 | 2023 | 133705 | 0.430 |
Why?
|
| Catalytic Domain | 1 | 2014 | 177 | 0.420 |
Why?
|
| Mice | 20 | 2021 | 18948 | 0.420 |
Why?
|
| Cell Membrane | 1 | 2015 | 487 | 0.410 |
Why?
|
| Membrane Proteins | 2 | 2011 | 1604 | 0.400 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2554 | 0.400 |
Why?
|
| Signal Transduction | 5 | 2021 | 4908 | 0.400 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 28 | 0.390 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 168 | 0.380 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 6 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2013 | 274 | 0.360 |
Why?
|
| Animals | 22 | 2023 | 36421 | 0.360 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 745 | 0.360 |
Why?
|
| Cadherins | 1 | 2012 | 186 | 0.350 |
Why?
|
| Chromatin | 3 | 2021 | 612 | 0.350 |
Why?
|
| RNA, Small Interfering | 7 | 2012 | 714 | 0.350 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1782 | 0.330 |
Why?
|
| G1 Phase | 5 | 2011 | 67 | 0.330 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 90 | 0.330 |
Why?
|
| Amino Acid Substitution | 3 | 2017 | 412 | 0.330 |
Why?
|
| DNA Helicases | 2 | 2023 | 251 | 0.310 |
Why?
|
| Receptors, Lysophosphatidic Acid | 2 | 2007 | 10 | 0.300 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 211 | 0.280 |
Why?
|
| ErbB Receptors | 2 | 2019 | 303 | 0.280 |
Why?
|
| Heterografts | 2 | 2019 | 199 | 0.260 |
Why?
|
| Autophagy | 1 | 2010 | 423 | 0.260 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2019 | 149 | 0.260 |
Why?
|
| Protein Isoforms | 2 | 2022 | 429 | 0.260 |
Why?
|
| Doxorubicin | 5 | 2008 | 300 | 0.260 |
Why?
|
| Lysophospholipids | 4 | 2007 | 33 | 0.250 |
Why?
|
| Tamoxifen | 2 | 2022 | 377 | 0.250 |
Why?
|
| Proteins | 5 | 1996 | 1093 | 0.250 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 5 | 2021 | 79 | 0.250 |
Why?
|
| Cisplatin | 3 | 2021 | 287 | 0.240 |
Why?
|
| Gene Expression | 2 | 2021 | 1616 | 0.240 |
Why?
|
| Protein Kinases | 3 | 2021 | 344 | 0.240 |
Why?
|
| Female | 11 | 2023 | 71603 | 0.230 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 22 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1327 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 644 | 0.220 |
Why?
|
| DNA Repair Enzymes | 1 | 2004 | 48 | 0.220 |
Why?
|
| Antigens, CD | 2 | 2012 | 452 | 0.220 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2023 | 11 | 0.220 |
Why?
|
| E2F Transcription Factors | 4 | 2004 | 26 | 0.210 |
Why?
|
| Endonucleases | 1 | 2023 | 58 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 212 | 0.210 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 127 | 0.200 |
Why?
|
| Mice, Nude | 3 | 2014 | 777 | 0.200 |
Why?
|
| Genes, p53 | 1 | 2023 | 234 | 0.200 |
Why?
|
| Neoplasms | 3 | 2014 | 3028 | 0.200 |
Why?
|
| Survival Analysis | 2 | 2021 | 1596 | 0.200 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 399 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1161 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2011 | 3173 | 0.180 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2021 | 6 | 0.180 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 1995 | 5 | 0.180 |
Why?
|
| Carcinogens | 1 | 2021 | 160 | 0.180 |
Why?
|
| DNA Adducts | 1 | 2021 | 82 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 802 | 0.170 |
Why?
|
| Protein Subunits | 2 | 2012 | 174 | 0.170 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 21 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 92 | 0.170 |
Why?
|
| Tumor Protein p73 | 2 | 2011 | 31 | 0.170 |
Why?
|
| G2 Phase | 1 | 2020 | 45 | 0.170 |
Why?
|
| E2F3 Transcription Factor | 3 | 2004 | 11 | 0.170 |
Why?
|
| Sumoylation | 1 | 2020 | 39 | 0.170 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 96 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 318 | 0.160 |
Why?
|
| RNA Interference | 2 | 2012 | 544 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 119 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2021 | 243 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2004 | 830 | 0.160 |
Why?
|
| Cyclins | 1 | 2020 | 104 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 716 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 786 | 0.160 |
Why?
|
| Thymus Gland | 3 | 2001 | 105 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1102 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 32 | 0.160 |
Why?
|
| Transfection | 5 | 2008 | 1090 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2000 | 106 | 0.150 |
Why?
|
| Herpesvirus 6, Human | 1 | 1999 | 55 | 0.150 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2000 | 186 | 0.150 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 63 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 396 | 0.150 |
Why?
|
| Cell Division | 1 | 2020 | 773 | 0.150 |
Why?
|
| Protein Transport | 1 | 2019 | 388 | 0.150 |
Why?
|
| LIM Domain Proteins | 4 | 2013 | 62 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1995 | 20 | 0.150 |
Why?
|
| Mutation | 6 | 2019 | 6294 | 0.140 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 147 | 0.140 |
Why?
|
| Biological Transport | 1 | 2018 | 369 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1006 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 732 | 0.140 |
Why?
|
| Disease Progression | 2 | 2022 | 2239 | 0.130 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1850 | 0.130 |
Why?
|
| Receptors, Antigen | 2 | 1996 | 34 | 0.130 |
Why?
|
| Cell Movement | 4 | 2013 | 917 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1999 | 445 | 0.130 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1995 | 10 | 0.120 |
Why?
|
| Models, Immunological | 1 | 1995 | 38 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 102 | 0.120 |
Why?
|
| Cell Adhesion | 2 | 2014 | 362 | 0.120 |
Why?
|
| CDC2 Protein Kinase | 2 | 2011 | 35 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2014 | 36 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 1995 | 584 | 0.110 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 70 | 0.110 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 275 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2014 | 1134 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 1994 | 549 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 204 | 0.110 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 233 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2898 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 2789 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 3971 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 433 | 0.110 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 41 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 669 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3991 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 1999 | 688 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1415 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2013 | 150 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2013 | 86 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 62 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 117 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 246 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2019 | 1145 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 185 | 0.100 |
Why?
|
| Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 2 | 0.100 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 20 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 669 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 542 | 0.090 |
Why?
|
| Cyclin A | 1 | 2011 | 18 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 73 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 270 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 58 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 1993 | 330 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 182 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2010 | 29 | 0.080 |
Why?
|
| Tenascin | 1 | 2010 | 32 | 0.080 |
Why?
|
| Camptothecin | 1 | 2010 | 78 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 110 | 0.080 |
Why?
|
| Protein Stability | 1 | 2010 | 172 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 92 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2008 | 281 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2010 | 54 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4793 | 0.070 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 32 | 0.070 |
Why?
|
| Cell Survival | 2 | 2010 | 889 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2008 | 317 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 248 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 68 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 140 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 72 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 78 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 163 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 231 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 673 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 402 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2013 | 688 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 100 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 119 | 0.060 |
Why?
|
| DNA | 3 | 2004 | 1677 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 62 | 0.060 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 351 | 0.060 |
Why?
|
| MutL Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2006 | 360 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 99 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 184 | 0.060 |
Why?
|
| Survival Rate | 1 | 2009 | 2217 | 0.050 |
Why?
|
| E2F2 Transcription Factor | 1 | 2003 | 6 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 134 | 0.050 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 10 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 645 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 82 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 866 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 232 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1535 | 0.050 |
Why?
|
| Etoposide | 1 | 2001 | 120 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 315 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 400 | 0.040 |
Why?
|
| Machine Learning | 1 | 2023 | 335 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 921 | 0.040 |
Why?
|
| Cladribine | 1 | 1999 | 9 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1439 | 0.040 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1999 | 17 | 0.040 |
Why?
|
| CD8 Antigens | 1 | 1999 | 45 | 0.040 |
Why?
|
| VDJ Recombinases | 2 | 1995 | 6 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 763 | 0.040 |
Why?
|
| Bone Marrow | 1 | 1999 | 335 | 0.030 |
Why?
|
| Periodicity | 1 | 1996 | 55 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 1995 | 15 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1995 | 41 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 195 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1995 | 108 | 0.030 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1994 | 18 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 451 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2005 | 97 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1995 | 613 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1993 | 122 | 0.030 |
Why?
|
| Zyxin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 563 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 20 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 69 | 0.030 |
Why?
|
| Cytosol | 1 | 2013 | 168 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 321 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1994 | 836 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1999 | 914 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2010 | 37 | 0.020 |
Why?
|
| Ploidies | 1 | 2010 | 38 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1994 | 1043 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 1046 | 0.020 |
Why?
|
| DNA Mismatch Repair | 1 | 2010 | 54 | 0.020 |
Why?
|
| Metallothionein | 1 | 1990 | 14 | 0.020 |
Why?
|
| Columbidae | 1 | 1990 | 20 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 67 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 905 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2013 | 374 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 7194 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 538 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 55 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1999 | 3167 | 0.020 |
Why?
|
| Tyrosine | 1 | 2005 | 159 | 0.010 |
Why?
|
| Paxillin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 26 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 26 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 158 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 166 | 0.010 |
Why?
|
| Male | 2 | 2000 | 65850 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 527 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 336 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 1878 | 0.010 |
Why?
|
| Aged | 1 | 2000 | 21674 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 456 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 29293 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 192 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 270 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1993 | 146 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 104 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 295 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1990 | 118 | 0.000 |
Why?
|
| Zinc | 1 | 1990 | 141 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 3172 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 364 | 0.000 |
Why?
|
| Amino Acids | 1 | 1990 | 687 | 0.000 |
Why?
|